Application experience of a rapid nucleic acid detection system for COVID-19

Chua, 2015, The case for improved diagnostic tools to control Ebola virus disease in west Africa and how to get there, PLoS Neglected Trop Dis, 9, 10.1371/journal.pntd.0003734 Zachariah, 2015, The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry?, Lancet Infect Dis, 15, 989, 10.1016/S1473-3099(15)00160-7 Li, 2020, Be alert to superposed effect of seasonal influenza while fighting against novel coronavirus pneumonia, Zhonghua Yufang Yixue Zazhi, 54, E002 Florkowski, 2017, Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?, Crit Rev Clin Lab Sci, 54, 471, 10.1080/10408363.2017.1399336 Nelson, 2020, Current and future point-of-care tests for emerging and new respiratory viruses and future perspectives, Front Cell Infect Microbiol, 10, 181, 10.3389/fcimb.2020.00181 Babady, 2013, The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens, Expert Rev Mol Diagn, 13, 779, 10.1586/14737159.2013.848794 Zhen, 2020, Clinical evaluation of three sample-to-answer platforms for detection of SARS-CoV-2, J Clin Microbiol, 58 Ulhaq, 2021, The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis, Expert Rev Mol Diagn, 21, 733, 10.1080/14737159.2021.1933449 Basu, 2020, Performance of Abbott ID Now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York city academic institution, J Clin Microbiol, 58, 10.1128/JCM.01136-20 Procop, 2021, A comparison of five SARS-CoV-2 molecular assays with clinical correlations, Am J Clin Pathol, 155, 69, 10.1093/ajcp/aqaa181 Lephart, 2021, Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type, Diagn Microbiol Infect Dis, 99, 115200, 10.1016/j.diagmicrobio.2020.115200 Rhoads, 2020, Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA emergency use authorization methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19, J Clin Microbiol, 58, 10.1128/JCM.00760-20 Zhen, 2020, Comparison of four molecular in vitro diagnostic assays for the detection of SARS-CoV-2 in nasopharyngeal specimens, J Clin Microbiol, 58, 10.1128/JCM.00743-20 Thwe, 2020, How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory, Diagn Microbiol Infect Dis, 98, 115123, 10.1016/j.diagmicrobio.2020.115123 2020 NMPA, 2020 Lesbon, 2021, Nucleocapsid (N) gene mutations of SARS-CoV-2 can affect real-time RT-PCR diagnostic and impact false-negative results, Viruses, 13, 10.3390/v13122474 Koyama, 2020, Variant analysis of SARS-CoV-2 genomes, Bull World Health Organ, 98, 495, 10.2471/BLT.20.253591 Metzger, 2021, PCR performance in the SARS-CoV-2 Omicron variant of concern?, Swiss Med Wkly, 151, w30120, 10.4414/SMW.2021.w30120 Gomes, 2021, Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR, J Virol Methods, 300, 114374, 10.1016/j.jviromet.2021.114374 Mancini, 2020, Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing, Emerg Microb Infect, 9, 1393, 10.1080/22221751.2020.1775500 2019 Chauhan, 2020, New and developing diagnostic platforms for COVID-19: a systematic review, Expert Rev Mol Diagn, 20, 971, 10.1080/14737159.2020.1816466 Gatoo, 2014, Physicochemical properties of nanomaterials: implication in associated toxic manifestations, BioMed Res Int, 2014, 498420, 10.1155/2014/498420 Ansari, 2010, Prospects of nanotechnology in clinical immunodiagnostics, Sensors (Basel), 10, 6535, 10.3390/s100706535 Cao, 2011, Gold nanoparticle-based signal amplification for biosensing, Anal Biochem, 417, 1, 10.1016/j.ab.2011.05.027 Sun, 2017, Self-assembled peptide nanomaterials for biomedical applications: promises and pitfalls, Int J Nanomed, 12, 73, 10.2147/IJN.S117501 Moabelo, 2021, Nanotechnology-based strategies for effective and rapid detection of SARS-CoV-2, Materials, 14, 10.3390/ma14247851 Li, 2019, CRISPR/Cas systems towards next-generation biosensing, Trends Biotechnol, 37, 730, 10.1016/j.tibtech.2018.12.005 Li, 2019, CRISPR/Cas multiplexed biosensing: a challenge or an insurmountable obstacle?, Trends Biotechnol, 37, 792, 10.1016/j.tibtech.2019.04.012 Chauhan, 2021, Optimizing testing regimes for the detection of COVID-19 in children and older adults, Expert Rev Mol Diagn, 21, 999, 10.1080/14737159.2021.1962708 Joung, 2020, Detection of SARS-CoV-2 with SHERLOCK one-pot testing, N Engl J Med, 383, 1492, 10.1056/NEJMc2026172 Broughton, 2020, CRISPR-Cas12-based detection of SARS-CoV-2, Nat Biotechnol, 38, 870, 10.1038/s41587-020-0513-4 Zhou, 2020, Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative, PLoS One, 15, 10.1371/journal.pone.0241469